Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-20-020524
Filing Date
2020-05-01
Accepted
2020-05-01 16:41:52
Documents
7
Period of Report
2020-05-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A pstv-pre14a_20200501.htm PRE 14A 969112
2 GRAPHIC g5g0xps0helv000008.jpg GRAPHIC 65224
3 GRAPHIC g5g0xps0helv000001.jpg GRAPHIC 49190
4 GRAPHIC g5g0xps0helv000006.jpg GRAPHIC 3731
5 GRAPHIC g5g0xps0helv000002.jpg GRAPHIC 3731
6 GRAPHIC g5g0xps0helv000004.jpg GRAPHIC 3731
7 GRAPHIC g5g0xps0helv000007.jpg GRAPHIC 80513
  Complete submission text file 0001564590-20-020524.txt   1250858
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-34375 | Film No.: 20841434
SIC: 3841 Surgical & Medical Instruments & Apparatus